Cara CDRM (Conduction Disturbance Risk Monitor) 2.0

NATerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 9, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Transcatheter Aortic Valve Replacement
Interventions
OTHER

ECG monitoring for Conduction Disturbances

Continuous ECG monitoring of Conduction Disturbances in patients undergoing TAVR procedure

Trial Locations (1)

55905

Mackram F. Eleid, M.D., Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cara Medical Ltd

INDUSTRY

NCT05465655 - Cara CDRM (Conduction Disturbance Risk Monitor) 2.0 | Biotech Hunter | Biotech Hunter